flavonoid/inflammation

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to flavonoid derivatives and, more particularly, to a flavonoid derivative or the pharmaceutically acceptable salt thereof that may be used in a pharmaceutical composition for preventing and treating cancer and

FIELD OF THE INVENTION The present invention relates to pharmaceutical compositions containing certain flavonoid glycoside-type compounds that have been shown in the present invention to be therapeutically useful, and in particular have been shown to be useful as analgesics and anti-inflammatory for

BACKGROUND OF THE INVENTION Research into the mechanism of inflammatory pain led to the discovery of the biochemical pathway associated with inflammation. One such example of chronic inflammatory pain is osteoarthritis. The elucidation of this pathway led to the association of the pro-inflammatory

FIELD OF THE INVENTION The present invention relates to inflammation, and novel combinations of active ingredients useful and synergistic for affecting the metabolic processes that underlie inflammatory processes and thereby treating or preventing inflammation. BACKGROUND OF THE INVENTION It has

FIELD OF THE INVENTION The present invention relates to inflammation, and novel combinations of active ingredients useful and synergistic for treating or preventing inflammation. BACKGROUND OF THE INVENTION Flavonoids are a diverse class of compounds found in a large variety of plants and herbs that

FIELD OF THE INVENTION The present invention relates to inflammation, and novel combinations of active ingredients useful and synergistic for treating or preventing inflammation. BACKGROUND OF THE INVENTION Flavonoids are a diverse class of compounds found in a large variety of plants and herbs that

FIELD OF THE INVENTION The present invention relates to compositions comprising eriocitrin, and their use for reducing IL-6 or MCP-1 levels, and as anti-oxidants and anti-inflammatory agents. BACKGROUND OF THE INVENTION Inflammation is associated with a number of diseases and conditions, including

FIELD OF THE INVENTION This invention relates generally to a composition of matter formulated for use in the prevention and treatment of neurodegradation, neuroinflammation and cumulative cognitive declines, disorders, diseases and conditions resulting from exposure to reactive oxygen species (ROS),

FIELD OF THE INVENTION This invention relates generally to a composition of matter formulated for use in the prevention and treatment of neurodegradation, neuroinflammation and cumulative cognitive declines, disorders, diseases and conditions resulting from exposure to reactive oxygen species (ROS),

FIELD OF THE INVENTION This invention relates generally to a composition of matter formulated for use in the prevention and treatment of neurodegradation, neuroinflammation and cumulative cognitive declines, disorders, diseases and conditions resulting from exposure to reactive oxygen species (ROS),

TECHNICAL FIELD The current invention, according to some embodiments, relates to methods of using antioxidant compositions to prevent, reduce, or eliminate the negative effects of oxidative damage or inflammation. In particular embodiments, the antioxidant compositions may be used with soft oral

The present invention deals with an Embelia extract--preferably an extract from Embelia concinna titrated in flavonoids--, its process for preparation and its use in a cosmetical or pharmaceutical composition for the treatment of skin sensitivity, for the treatment of allergic reactions of the skin,

CROSS REFERENCE TO RELATED APPLICATION This application claims the priority of Korean Patent Application No. 10-2013-0089727, filed on Jul. 29, 2013 in the KIPO (Korean Intellectual Property Office). Further, this application is the National Phase application of International Application No.

BACKGROUND OF THE INVENTION The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan and a flavonoid compound that are designed to be

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to novel flavonoids extracted from an alcohol extract of dehulled adlay seeds and uses thereof. 2. Description of the Related Art Chronic inflammation contributes to the pathogenesis of a number of diseases that affect a